Leigh Syndrome Organoid Drug Screen Identified Talarozole and Sertaconazole
TL;DR: A 2026 study in Nature Communications used deep learning, yeast screening, and human brain organoids to identify talarozole and sertaconazole as preclinical candidates that rescued several SURF1-related Leigh syndrome cell and organoid phenotypes. Key Findings 2,250-drug yeast screen: Researchers screened a repurposable-drug library in a yeast model carrying a SURF1-homologue defect and selected top …
